Last quarter (Q3 2017), Biostar Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Biostar Pharmaceuticals's net income was $-654.86K. See Biostar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 16
Total Revenue
$ 2.38M
Gross Profit
$ 915.17K
Operating Expenses
$ 4.48M
Depreciation and Amortization
$ 1.14M
EBITDA
$ -1.70M
Operating Income
$ -3.56M
Other Income/Expenses
$ 518.93K
Pretax Income
$ -3.05M
Net Income
$ -5.70M
Per Share Metrics
Basic EPS
$ -2.48
Diluted EPS
$ -2.48
Weighted Average Shares Outstanding
2.30M
Weighted Average Shares Outstanding (Diluted)
2.30M
Currency in USD
Biostar Pharmaceuticals Earnings and Revenue History